Physician profile
Maxime Madhere
NPI 1295961605
$792.34
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2021: $65.41 · 2022: $237 · 2023: $218 · 2024: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $291.66 | 2022-2023 | Amplatzer Amulet |
| Edwards Lifesciences Corporation | $177.47 | 2019-2024 | |
| Abiomed | $163.74 | 2022-2023 | Impella |
| Spr Therapeutics, INC | $35.95 | 2021 | |
| Chiesi USA, INC. | $31.17 | 2019-2021 | |
| Medtronic, INC. | $31.12 | 2024 | Mcgrath Mac |
| Silk Road Medical, INC. | $18.10 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Argon Medical Devices, INC. | $15.63 | 2024 | Clot Management |
| Acacia Pharma INC | $14.79 | 2021 | |
| Boston Scientific Corporation | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxime Madhere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.